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bstract
A complete physicochemical characterisation of MDMA and its synthetic precursors MDA, 3,4-methylenedioxybenzaldehyde (piperonal) and
,4-methylenedioxy--methyl--nitrostyrene was carried out through voltammetric assays and Raman spectroscopy combined with theoretical
DFT) calculations. The former provided important analytical redox data, concluding that the oxidative mechanism of the N-demethylation of
DMA involves the removal of an electron from the amino-nitrogen atom, leading to the formation of a primary amine and an aldehyde. The
ibrational spectroscopic experiments enable to afford a rapid and reliable detection of this type of compounds, since they yield characteristic
pectral patterns that lead to an unequivocal identification.Moreover, the rational synthesis of the drug of abuse 3,4-methylenedioxymethamphetamine (MDMA or “ecstasy”) from one of its most relevant
recursors 3,4-methylene-dioxyamphetamine (MDA), is reported. In addition, several approaches for the N-methylation of MDA, a limiting
ynthetic step, were attempted and the overall yields compared.
2007 Elsevier B.V. All rights reserved.
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. Introduction
The amphetamine analogues 3,4-methylenedioxymetha-
phetamine (MDMA, “ecstasy”) and 3,4-methylenedioxy-
mphetamine (MDA) are popular recreational drugs mainly
ue to their stimulant effects on the central nervous system
nd increased sense of well being [1–4]. These compounds
re ring-substituted phenethylamines, structurally related to
oth psychomotor stimulant amphetamines and the hallucino-
∗ Corresponding author at: Departamento de Quı´mica Orgaˆnica, Faculdade de
arma´cia, Universidade do Porto, 4050-047 Porto, Portugal.
el.: +351 222078900; fax: +351 222003977.
E-mail address: fborges@ff.up.pt (F. Borges).
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oi:10.1016/j.aca.2007.06.027Voltammetry; Density functional theory calculations
en mescaline. MDMA is nowadays a commonly misused drug,
hus giving rise to a serious public health problem repeatedly
ssociated with serotoninergic neurotoxicity [4–6].
All methylenedioxy-containing amphetamines became very
opular after modification of the MDA structure in clandestine
aboratories, by replacement of one or two hydrogens in the
itrogen atom by alkyl groups, yielding several distinct com-
ounds with high potential for abuse. In fact, the simple addition
f a N-methyl group is responsible for a decrease in the temporal
ourse of action of the drug to less than half, as well as for a
eduction (or even a disappearance) of the hallucinogenic effects
ssociated to MDA [1].
MDA, besides other compounds, is frequently described as
n impurity in the MDMA synthetic process. It is also produced
232 N. Milhazes et al. / Analytica Chim
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(ig. 1. General procedure for the synthesis of MDA. Chemical conditions: (a)
tNO2, NH4CH3COO, reflux; (b) LiAlH4, THF, reflux.
etabolically by N-demethylation of MDMA, hence becoming
ts major metabolite in a short time after ingestion. This biotrans-
ormation step is thought to proceed through a carbinolamine
ntermediate, formed by cytochrome P-450 mediated oxidation
f the -carbon to the N-methyl group, or through N-oxidation
ollowed by rearrangement to a primary amine [7,8]. Accord-
ngly, the knowledge of conceptual biotransformation, in which
xidation reactions play a major role [9], is absolutely critical
o understand the toxicity of this kind of compounds.
The present work reports the total synthesis of MDA and
DMA. Firstly, the preparation of MDA was based on a well-
nown synthetic procedure, often described in the literature as
ne of the main routes for the manufacture of amphetamines
10–12], that relies upon the synthesis of the appropriate
-methyl--nitrostyrene precursor (Fig. 1). Secondly, several
ifferent pathways for N-methylation of MDA were investigated
Fig. 2), since this step is known to be limiting.
The oxidative electroactivity of MDMA and its synthetic
recursors MDA, 3,4-methylenedioxybenzaldehyde (piperonal)
nd 3,4-methylenedioxy--methyl--nitrostyrene (Fig. 1) was
tudied using voltammetric techniques. Besides the putative ana-
ytical interest, the results thus gathered can hopefully help to
larify the hypothetical in vivo N-demethylation oxidation pro-
ess. Actually, MDMA metabolism is known to comprise one
r more oxidative pathways [13].
Furthermore, a conformational characterisation of MDMA
nd MDA was carried out through Raman spectroscopic exper-
ments combined to quantum mechanical (DFT) calculations.
lthough there are some reported studies on the Raman analysis
f amphetamine-like compounds [14–21], these experiments
ave only focused on particular regions of the vibrational
pectra.
m
a
l
ig. 2. Strategies used for the synthesis of MDMA using MDA as starting material. M
0 h. Ic: Cs2CO3, MeOH, H2O; Δ, 2 h (overall yield: 41.6%). Method II—IIa: ClCO
1.7%). Method III: HCHO, NaBH3CN, MeOH, AcOH; rt, 3 h (overall yield: 33.3%
overall yield: 37.1%).ica Acta 596 (2007) 231–241
. Experimental
.1. Chemicals
Ethyl formate, lithium aluminium hydride (1 M solution in
HF), pyridine, trifluoroacetic anhydride, formaldehyde (37%
olution in water), sodium cyanoborohydride, sodium hydride
60% dispersion in mineral oil), methyl iodide, ethyl chlorofor-
ate, cesium carbonate and all the dry solvents were purchased
rom Sigma–Aldrich Quı´mica S.A. (Sintra, Portugal). All other
eagents and solvents (pro analysis grade) were acquired from
erck (Lisbon, Portugal). All reagents were used without fur-
her purification. Deionised water (conductivity <0.1S cm−1)
as used in all experiments.
.2. Synthesis
.2.1. Structural elucidation
1H and 13C NMR data were acquired, at room tempera-
ure, on a Bru¨ker AMX 300 spectrometer operating at 300.13
nd 75.47 MHz, respectively. Dimethylsulfoxide-d6 was used
s a solvent; chemical shifts being expressed in δ (ppm) values
elative to tetramethylsilane (TMS) (as internal reference); cou-
ling constants (J) are in Hz. Spectral assignments were also
ade from DEPT (Distortionless Enhancement by Polarization
ransfer) experiments (italicised values). Electron impact mass
pectra (EI-MS) were obtained on a VG AutoSpec instrument;
ata are reported as m/z (% of relative intensity for the most
mportant fragments). Melting points were measured on a Ko¨fler
icroscope (Reichert Thermovar) and are uncorrected. All the
ntermediates of the following syntheses were identified by mass
pectroscopy and were found to be the described compounds.
.2.2. Chromatographic conditions
The analytical control was performed by thin-layer chro-
atography (TLC) on plates precoated with silica gel 60 F254
s stationary phase (0.2 mm as layer thickness) and the fol-
owing mobile phases: petroleum ether/diethyl ether/formic
ethod I—Ia: O(COCF3)2, Pyr, CH2Cl2; 0 ◦C, 2 h. Ib: NaH, CH3I, DMF; 20 ◦C,
OC2H5, NaOH, H2O; 0 ◦C, 1.5 h. IIb: LiALH4, THF; Δ, 13 h (overall yield:
). Method IV—IVa: HCOOC2H5; Δ, N2, 6 h. IVb: LiAlH4, THF; Δ, N2, 4 h
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and extracted with diethyl ether (3× 100 mL). The organic layerN. Milhazes et al. / Analytica
cid (5:5:0.1); chloroform/acetone/formic acid (8:2:0.1); chloro-
orm/methanol/formic acid (7:3:0.1). The spots were visualised
nder UV detection (254 and 366 nm) and iodine vapour.
The purity of the final products (>98% purity) was veri-
ed using a high-performance liquid chromatography (HPLC)
ystem equipped with UV detector. HPLC-UV chromatograms
ere obtained in a Jasco instrument (pumps model 880-PU and
olvent mixing model 880-30, Tokyo, Japan), equipped with a
ucleosil RP-18 column (250 mm × 4.6 mm, 5m, Macherey-
agel, Du¨ren, Germany), and UV detection at 280 nm (Jasco
odel 875-UV). pH 3 phosphate buffer/methanol (6:1) was used
s the mobile phase, in isocratic flow rate of 1.2 mL min−1. The
hromatographic data was processed in a Compaq computer,
tted with CSW 1.7 software (DataApex, Czech Republic).
.2.3. Synthesis of MDA (3,4-methylenedioxyamphetamine)
MDA was synthesised by an adaptation of a previous
escribed method (Fig. 1) [11]. Briefly, a Henry reac-
ion between nitroethane and piperonal (3,4-methylene-
ioxybenzaldehyde) was performed through basic catalysis of
mmonium acetate followed by water elimination. The result-
ng -methyl--nitrostyrene derivative was then reduced to the
orresponding phenethylamine (MDA) by lithium aluminium
ydride. The obtained free base oil was used straightforward
nto the next syntheses.
(R,S)-3,4-Methylenedioxyamphetamine hydrochloride
MDA).1H NMR δ: 1.10 (3H, d, CH3), 2.60 (1H, dd, J = 13.4;
.5, CH2), 2.89 (1H, dd, J = 13.4; 5.2, CH2), 3.35 (1H, m, CH),
.99 (2H, s, OCH2O), 6.62 (1H, dd, J = 7.8; 1.2, H(6)), 6.74
1H, d, J = 1.2, H(2)), 6.78 (1H, d, J = 7.9, H(5)), 8.08 (3H,
s, NH3+); 13C NMR δ: 17.6 CH3, 39.7 CH2, 48.0 CH, 100.8
OCH2O), 108.3, 109.5 C(2) and C(5), 122.4 C(6), 130.4 C(1),
46.0 C(3), 147.4 C(4); EI-MS m/z (%): 179 (M•+, 3), 162
4), 136 (100), 105 (12), 82 (8), 77 (35), 65 (5), 58 (8); mp
86–188 ◦C.
.2.4. Synthesis of 3,4-methylenedioxymethamphetamine
MDMA, “ecstasy”)
.2.4.1. Method I. (Ia) N-Trifluoroacetyl-3,4-methylenedi-
xyamphetamine: MDA as a free base (3.55 g, 19.8 mmol) was
issolved in dry dichloromethane (30 mL), under nitrogen, with
he following addition of pyridine (2.3 mL, 28.5 mmol). The
olution was ice-cooled and trifluoroacetic anhydride (3.8 mL,
7.3 mmol) was added dropwise to the reaction vessel. The
ixture was allowed to reach room temperature and stirred for
ore 2 h. The solution was washed with water (30 mL) and the
rganic layer dried (MgSO4) and evaporated under reduced
ressure. The obtained residue (5.17 g, 18.8 mmol) was purified
y column chromatography (silica gel; petroleum ether/diethyl
ther (7:3)).
(Ib) N-Trifluoroacetyl-3,4-methylenedioxymethamphet-
mine: N-Trifluoroacetyl-3,4-methylenedioxyamphetamine
5.17 g, 18.8 mmol) was dissolved in DMF (25 mL) and a
0% dispersion in mineral oil of sodium hydride (0.80 g,
3.3 mmol) was added to the solution. The reaction was stirred
uring 2 h at room temperature. Then methyl iodide (1.3 mL,
0.9 mmol) was added and the mixture was stirred for further
w
c
M
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h. After this time the reaction medium was transferred to a
essel containing a 0.1 M solution of acetic acid (15 mL). The
roduct was extracted with dichloromethane (3× 50 mL) and
he organic phase was dried (MgSO4) and evaporated under
educed pressure. The product was subsequently purified by
C to remove the mineral oil (silica gel; dichloromethane/ethyl
cetate in different proportions) (3.34 g, 11.5 mmol).
(Ic) 3,4-Methylenedioxymethamphetamine (MDMA):
o a solution of N-trifluoroacetyl-3,4-methylenedioxyme-
hamphetamine (3.34 g, 11.5 mmol) in a mixture of
ethanol/water (1:1) (30 mL) cesium carbonate (8.48 g,
6.0 mmol) was added and the resulting mixture was refluxed
or 1.5 h. After partial evaporation of the solvent and sequential
ddition of water (70 mL), the compound was extracted with
thyl acetate (2× 100 mL). The solvent was dried over magne-
ium sulphate and evaporated. The residue was recrystallised
ith methanol acidified with HCl and the MDMA hydrochlo-
ide was obtained as white solid product after addition of
iethyl ether (1.89 g, overall yield: 41.6%).
(R,S)-3,4-Methylenedioxymethamphetamine hydrochloride
MDMA). 1H NMR δ: 1.08 (3H, d, CH3), 2.54 (3H, s, NCH3),
.56 (1H, dd, J = 13.4; 8.7, CH2), 3.04 (1H, dd, J = 13.4; 4.5,
H2), 3.33 (1H, m, CH), 5.99 (2H, s, OCH2O), 6.70 (1H, dd,
= 8.0; 1.6, H(6)), 6.86 (1H, d, J = 1.6, H(2)), 6.87 (1H, d, J = 7.9,
(5)), 8.78 (2H, bs, NH2+); 13C NMR δ: 14.8 CH3, 29.4 NCH3,
7.7 CH2, 55.1 CH, 100.7 OCH2O, 108.1, 109.3 C(2) and C(5),
22.2 C(6), 130.6 C(1), 146.3 C(3), 147.7 C(4); EI-MS m/z (%):
93 (M•+, 9), 178 (12), 163 (10), 135 (100), 105 (25), 89 (28),
3 (16), 77 (98); mp 148–150 ◦C.
.2.4.2. Method II. (IIa) N-Carbethoxy-3,4-methylenedioxy-
mphetamine: MDA (0.81 g, 4.5 mmol) as a free base was dis-
olved in water (30 mL) at 0 ◦C. A solution of NaOH (0.3 g)
n water (2.5 mL) was then added to the reaction with following
ddition of ethyl chloroformate (0.5 mL, 5.3 mmol). The suspen-
ion was stirred at 0 ◦C for 2 h and the reaction was then stopped
y extraction with dichloromethane (3× 100 mL). The organic
ayer was dried (Na2SO4) and the solvent was evaporated to
btain the corresponding carbamate (0.95 g, 3.8 mmol).
(IIb) 3,4-Methylenedioxymethamphetamine (MDMA): The
arbamate (0.95 g, 3.8 mmol) was dissolved in THF (15 mL)
nd this solution was slowly added to lithium aluminium hydride
12 mmol) suspended in THF (25 mL), under N2. The reaction
as stirred, heated under reflux for 10 h and then allowed to cool
o room temperature. The excess of LiAlH4 was decomposed
nd the reaction quenched by smooth addition of cold water/ice
ith vigorous stirring. The inorganic residue was removed by
acuum filtration; the solvent was dried over anhydrous magne-
ium sulphate, evaporated, the residue diluted with diethyl ether
nd extracted with aqueous HCl (3× 100 mL of a 2 M solu-
ion). The acidic extract was alkalinised with a NaOH solutionas dried over anhydrous magnesium sulphate, filtered and con-
entrated to yield a light coloured oil turned into a white solid of
DMA hydrochloride by the addition of ethereal HCl (0.53 g,
verall yield: 51.7%).
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.2.4.3. Method III. MDA (2.00 g, 11.7 mmol) as a free base
as dissolved in methanol (50 mL) acidified with acetic acid
ntil pH 5. Formaldehyde (1 mL of a 37% solution in water,
2.3 mmol) and sodium cyanoborohydride (0.98 g, 15.6 mmol)
ere then slowly added to the solution. The reaction was stirred
t room temperature during 3 h. After that the solvent was evap-
rated and the resulting yellowish oil was dissolved in methanol,
he solution was acidified with HCl and diethyl ether was
dded until insolubilisation. A white solid identified as MDMA
ydrochloride was obtained (0.89 g, yield: 33.3%).
.2.4.4. Method IV. (IVa) N-Formyl-3,4-methylenedioxyam-
hetamine: MDA (1.59 g, 8.9 mmol) as a free base was sus-
ended in ethyl formate (50 mL) and the ensuing mixture was
eated to reflux providing a homogeneous solution. After 6 h,
he excess of ethyl formate was removed under reduced pres-
ure, and the resulting yellow solid of the formamide (1.59 g,
.7 mmol) was identified and used without further purification
n the next reaction.
(IVb) 3,4-Methylenedioxymethamphetamine (MDMA): A
olution of N-formyl-3,4-methylenedioxyamphetamine (1.59 g,
.7 mmol) in anhydrous tetrahydrofuran (25 mL) was added
ropwise to a stirred solution of lithium aluminium hydride
15 mmol) in anhydrous tetrahydrofuran (35 mL), while cool-
ng with ice-water in an inert environment (N2). The mixture
as allowed to warm up to room temperature and then refluxed
or 4 h more. After cooling and decomposing the hydride excess
y the cautious addition of water, the precipitated inorganic salts
ere eliminated by filtration. The combined organic solutions
ere dried over sodium sulphate and concentrated to yield a
ellow oil that was dissolved in methanol and acidified with an
thereal solution of HCl to obtain a almost white solid identified
s MDMA (0.76 g, overall yield: 37.1%).
.3. Electrochemical measurements
For the electrochemical measurements, 10 mM stock
olutions of MDMA, MDA, 3,4-methylenedioxy--methyl-
-nitrosyrene and piperonal were made by dissolving an
ppropriate amount of compound in water or ethanol, depend-
ng on their solubility. The voltammetric working solutions were
repared, in the electrochemical cell, by diluting 100L of the
tock solution in 10 mL of supporting electrolyte, in order to get
final concentration of 0.1 mM.
The pH 7.3 supporting electrolyte used in the voltammet-
ic determinations was prepared by diluting 6.2 mL of 0.2 M
ipotassium hydrogen phosphate and 43.8 mL of 0.2 M potas-
ium dihydrogen phosphate to 100 mL.
Voltammetric studies were performed using an Autolab
GSTAT 12 potentiostat/galvanostat (Eco-Chemie, Nether-
ands) and a one-compartment glass electrochemical cell.
oltammetric curves were recorded, at room temperature and
ithout oxygen purging, using a three-electrode system. A
lassy carbon working electrode (GCE) (d = 2 mm), a platinum
ire counter electrode and an Ag/AgCl saturated KCl refer-
nce electrode were used. The working electrode was polished
anually with aqueous slurry of alumina powder (BDH) on a
s
a
f
aica Acta 596 (2007) 231–241
icrocloth pad and rinsed with water before use. A Crison pH-
eter with glass electrode was used for the pH measurements
Crison, Spain).
.4. Quantum mechanical calculations
The quantum mechanical calculations – geometry optimi-
ation and calculation of the harmonic vibrational frequencies
were performed using the GAUSSIAN 98W program [22],
ithin the Density Functional Theory (DFT) approach in order
o properly represent the electron correlation effects. The B3LYP
ybrid method, which includes a mixture of HF and DFT
xchange terms and the gradient-corrected correlation func-
ional of Lee et al. [23,24] as proposed and parameterised by
ecke [25,26], was used, along with the double-zeta split valence
asis set 6-31G* [27].
Molecular geometries were fully optimised by the Berny
lgorithm, using redundant internal coordinates [28]: the bond
engths to within ca. 0.1 pm and the bond angles to within ca.
.1◦. The final root-mean-square (rms) gradients were always
ess than 3 × 10−4 hartree bohr−1 or hartree radian−1. No geo-
etrical constraints were imposed on the molecules under study.
Frequency calculations were run, at the B3LYP/6-31G* level,
or all the energy minima obtained for the molecules under study.
n view of accounting for the anharmonicity, wavenumbers
bove 400 cm−1 were scaled using a factor of 0.9614 accord-
ng to Scott and Radom [29], before comparing them with the
xperimental data.
.5. Raman spectroscopy
The Raman spectra were obtained at room temper-
ture, on a triple monochromator Jobin-Yvon T64000
aman system (0.640 m, f/7.5), with holographic gratings of
800 grooves mm−1. The detection system was a non-intensified
CD (Charge Coupled Device). The entrance slit was set to
00m and the slit between the premonochromator and the
pectrograph was opened to 14.0 mm. The 514.5 nm line of an
r+ laser (Coherent, model Innova 300) was used as the excita-
ion radiation, providing between 10 and 50 mW at the sample
osition. Samples were sealed in Kimax glass capillary tubes of
.8 mm inner diameter. Under the above-mentioned conditions,
he error in wavenumbers was estimated to be within 1 cm−1.
. Results and discussion
.1. Chemistry
The synthesis of MDMA from MDA is outlined in Fig. 2 and
he related structural elucidation data is presented in Section 2.
In general, amines can be N-alkylated through several path-
ays by the use of a key property of the nitrogen atom, its
ucleophilicity. The alkylation methods are usually indirect,
ince the reaction of amines with haloalkanes is usually slow
nd not clean. Indeed, the N-methylation of a primary amine
requently results in a mixture of the secondary and the tertiary
mine. Due to this difficulty four indirect alkylation processes
Chimica Acta 596 (2007) 231–241 235
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ere designed, experimented and compared (methods I–IV),
iming at an improvement of the overall yield and of the purity
f the final product.
Briefly, in the first procedure (method I), a simple modifica-
ion of the direct method was chosen, in which a trifluoroacetyl
roup is used to generate an acetamide derivative (N-COCF3,
-TFA). This group is readily attached to the nitrogen atom
y reaction of the primary amine with trifluoroacetic anhydride
(CF3CO)2O) in the presence of a base (triethylamine or pyri-
ine), at low temperature [30,31]. Then, after N-alkylation with
ethyl iodide, the resultingN-methyltrifluoroacetamide is easily
leaved (N-deacylation) in basic conditions [30].
On the other hand, method II is based on the synthesis of a car-
amate intermediate (NCOOR), a classic example of protecting
roup for amines. The most common one is the ethylcarbamate
NCOOCH2CH3), a group obtained by reaction of the amine
ith ethyl chloroformate in the presence of a base (Method II).
his group is usually reduced by most of hydrides, like LiAlH4,
iving the corresponding N-methylamines [32].
Method III seemed an attractive approach to MDMA synthe-
is from MDA since it corresponds to a one-pot reaction in which
DA is treated with an aldehyde (formaldehyde) in the presence
f sodium cyanoborohydride as a catalyst. In these synthetic
onditions the amine group undergoes a reductive methylation
31,33].
Method IV is based on a N-formylation of the primary
mine (MDA) with ethyl formate (HCO2Et) providing the cor-
esponding formamide intermediate (IVa) which after reduction
l
h
r
a
ig. 4. Cyclic voltammograms for 0.1 mM solutions of (a) 3,4-methylenedioxybenz
DMA, in physiological pH 7.3 supporting electrolyte. Scan rate: 50 mV s−1.DMA, (· · ·) MDA, (- - -) 3,4-methylenedioxybenzaldehyde and (- · - ·) 3,4-
ethylenedioxy--methyl--nitrostyrene, in physiological pH 7.3 supporting
lectrolyte. Scan rate: 5 mV s−1.
ith lithium aluminium hydride gave the N-methyl compound
MDMA) [34,35] in relative good yields.
It is worth mentioning that the synthesised amines were iso-
ated and used in the analytical assays after obtention of their
ydrochloride salts. However, prior to the N-methylation, the
egeneration of the base from its salt form must be conducted
fter alkalinisation with ammonia. This step is important since
aldehyde, (b) 3,4-methylenedioxy--methyl--nitrostyrene, (c) MDA and (d)
2 Chimica Acta 596 (2007) 231–241
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he lone pair of electrons on the nitrogen was unavailable to the
sual reactions involving amines (alkylation and/or oxidation).
.2. Electrochemical oxidation
To increase the understanding of the redox profile of the
rugs, important for the advance of the knowledge of molecular
oxicological mechanisms and the development of new analyt-
cal assays, the electrochemical behaviour of MDMA, MDA
nd their synthetic precursors 3,4-methylenedioxybenzaldehyde
piperonal) and 3,4-methylenedioxy--methyl--nitrostyrene
as studied at physiological pH, at a glassy carbon working
lectrode (GCE) using differential pulse and cyclic voltammetry.
For MDMA, two well-defined anodic peaks can be observed
t physiological pH using differential pulse voltammetry
Fig. 3). The first oxidation peak, Ep = +1.05 V, is probably
ue to the removal of one electron from the aromatic nucleus.
he second wave, Ep = +1.26 V, corresponds to the oxidation
f the secondary amine present in the MDMA molecule. Cyclic
oltammograms were also recorded at different sweep rates. Two
ell-defined anodic peaks were observed for MDMA at phys-
ological pH (Fig. 4). The fact that no peaks were observed in
he reversed scan suggests that the oxidation processes are irre-
ersible. These peaks correspond to the above-described waves
bserved by differential pulse voltammetry.
The electrochemical study of MDMA synthetic impurities,
DA, 3,4-methylenedioxybenzaldehyde (piperonal) and 3,4-
ethylenedioxy--methyl--nitrostyrene enabled to get insight
he established mechanistic hypothesis that the groups involved
n the oxidation of MDMA are the aromatic electrophore and
he secondary amine. For these compounds, only a single and
ell-defined anodic oxidation wave is noticed at physiological
H that can be attributed to the removal of one electron from
he aromatic nucleus. Cyclic voltammetric measurements per-
ormed showed the irreversible nature of the oxidation waves for
hese compounds (Fig. 4). The differences observed for these
ompounds in terms of peak potential and peak current may be
ue to the nature and electrophilic properties of the substituent
n the aromatic ring.
The only structural difference between MDMA and MDA
ies in the amine group, MDMA has a secondary and MDA
primary amine group. Thus, the second wave observed for
DMA could only be related with the oxidation of the secondary
mine group. The appearance of a peak at this Ep value resulting
rom the oxidation of aliphatic secondary amines has also been
escribed in the literature for other aliphatic amines [36,37].
revious published works using compounds structurally related
ith MDMA also showed the occurrence of an anodic wave that
as been undoubtedly attributed to the oxidation of the secondary
mine [37–39].
The first peak observed for MDMA, Ep = +1.05 V, ascribed to
he oxidation of the aromatic electrophore also occurs for MDA,
p = +1.06 V. The inexistence of other groups in the molecule
apable of being oxidised could itself justify this attribution.
n addition, it could be found in literature some studies involv-
ng compounds possessing similar functionalities that present a
ave at similar potentials to that established for MDMA and
s
(
“onformers for the hydrochloride salts of 3,4-methylenedioxyamphetamine
MDA) (A) and 3,4-methylenedioxymethamphetamine (MDMA) (B). (The
tom numbering is included.)
DA and that were also directly related to the oxidation of the
romatic ring [40,41].
Besides the importance of redox data for toxicological stud-
es, in which metabolism is an important pathway, its importance
s noteworthy for analytical forensic assays in which an elec-
rochemical detector is often used due to its sensitivity and
electivity (e.g. HPLC).
.3. Conformational analysis
The geometry optimisation carried out for both MDA and
DMA (“ecstasy”) hydrochlorides allowed to obtain their low
nergy conformers represented in Fig. 5. The corresponding
heoretical vibrational spectra were yielded by the harmonic
requency calculations (which also confirmed these geometries
s real minima in the potential energy surface). In MDA and
DMA the unsaturated aliphatic (C7C8N10) side chain was
ound to be almost perpendicular relative to the coplanar aro-
atic and methylenedioxy rings – (C2C1C7C8) equal to 73.9◦
or “ecstasy” and 75.4◦ for MDA (Table 1) – thus minimising
teric repulsions between the C8-methyl and aromatic hydrogens
H15 or H18).
N-Methylation of MDA, yielding its N-methyl analogue
ecstasy” (MDMA), occurs in a trans position relative to the
N. Milhazes et al. / Analytica Chimi
Table 1
Relevant calculated (B3LYP/6-31G*) geometric parameters for the most stable
conformers of MDA and MDMA
MDA MDMA
μ (D)a (8.4) (8.8)
Bond lengths (pm)
C1–C2b 141.4 141.4
C3–C4 139.4 139.4
C5–C6 140.8 140.8
C1–C7 151.4 151.5
C7–C8 154.4 154.4
C8–C9 152.7 152.9
C3–O13 137.4 137.4
C4–O14 137.4 137.5
C16–O13 143.3 143.3
C8–N10 150.3 150.9
C27–N10 – 148.2
C2–H15 108.6 108.6
C16–H23 109.4 109.4
C7–H19 110.0 109.7
C8–H26 109.8 109.9
C9–H20 109.7 109.7
C9–H21 109.2 109.2
N10–H11 122.0 116.3
N10–H12 102.2 102.2
C27–H28 – 109.2
C27–H29 – 109.4
Bond angles (◦)
C6–C1–C2 119.7 119.7
C6–C1–C7 120.5 120.6
C1–C7–C8 113.2 112.8
C7–C8–C9 113.9 113.2
O13–C16–O14 108.1 108.0
C4–C3–O13 109.7 109.7
C3–O13–C16 105.7 105.6
C7–C8–N10 107.6 109.7
C8–N10–C27 – 117.3
C1–C7–H19 109.4 108.9
C7–C8–H26 109.3 109.5
C8–C9–H20 111.1 111.2
O13–C16–H23 109.4 109.4
N10–C27–H28 – 108.3
N10–C27–H29 – 110.8
H20–C9–H21 107.9 107.9
H23–C16–H24 110.9 111.0
Dihedral angles (◦)
C1–C2–C3–C4 0.0 −0.1
C3–C2–C1–C7 −179.4 −179.8
C2–C1–C7–C8 75.4 73.9
C1–C7–C8–C9 64.6 62.6
C1–C7–C8–N10 −175.6 −177.6
C7–C8–N10–C27 − 65.2
C7–C8–N10–H11 −61.2 −57.0
C7–C8–N10–H12 179.5 −170.7
C2–C3–O13–C16 174.2 173.6
C3–O13–C16–O14 10.6 11.6
C3–O13–C16–H23 129.6 130.7
C6–C1–C2–H15 −179.1 −179.1
C6–C1–C7–H19 134.9 132.3
C1–C7–C8–H26 −58.7 −60.5
C7–C8–C9–H20 −177.9 −177.3
C8–N10–C27–H28 – 171.3
a D = 1/3 × 10−2 C m.
b Atoms are numbered according to Fig. 5.
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ethyl group in C8 ((C9C8N10C27) = −171.5◦, Fig. 5), in order
o avoid repulsion effects between the two adjacent CH3 groups.
oreover, inclusion of the methyl group in the terminal amino
oiety of the molecule is associated to a slight decrease of
he (C1C7C8C9) dihedral angle – from 64.6◦ in MDA to 62.6◦
n “ecstasy” – coupled to an increase for (C1C7C8N10) –
rom −175.6◦ in MDA to −177.6◦ in “ecstasy” (Table 1).
-Methylation also leads to a slight variation of the relative
rientation of the C8–C9 bond relative to the plane of the rings
(C9C8C1C6) = −26.4◦ in MDA to −29.9◦ in MDMA – as
ell as to a reorientation of the amino group – (C7C8N10H11)
nd (C7C8N10H12) equal to −61.2◦ and 179.5◦ in MDA versus
57.0◦ and −170.7◦ in “ecstasy” (Table 1).
.4. Raman spectroscopy
The Raman spectra of MDA and MDMA are represented
n Fig. 6 (from 100 to 1750 cm−1), along with the spectra
f their synthetic precursors 3,4-methylene-dioxybenzaldehyde
piperonal) and 3,4-methylenedioxy--methyl--nitrostyrene.
he corresponding vibrational wavenumbers were assigned
n the light of the theoretical results presently carried out
Table 2) and the spectroscopic data previously reported for
-methyl--nitrostyrene derivatives [42–45] and similar com-
ounds [46–52].
As previously verified [42], Raman spectroscopy proved
o be quite adequate for a rapid and reliable characterisa-
ion of this type of system. In fact, the spectral patterns
btained in this work allow an unequivocal identification of
he amphetamine MDA and the corresponding N-methyl deriva-
ive MDMA (“ecstasy”) (Figs. 6 and 7). The former displays
ypical Raman bands at 836/861 cm−1 (CH2 in-plane defor-
ation, δ(CH2)/CH2 wagging, ω(CH2)), 985–965 cm−1 (NH3
ocking, r(NH3)), 1024 cm−1 (OCO ring deformation, δ(OCO)),
310/1319 cm−1 (NH3 in-plane deformation, δ(NH3)), and
355 cm−1 (r(NH3)). MDMA, in turn, presents characteristic
ignals at 381–479 cm−1 (skeletal CCC, COC and CCN out-
f-plane deformations, Γ (CCC/COC,CCN)), 855 cm−1 (NH2
ocking, r(NH2)), 888/1040/1081 cm−1 (rocking of the N-
ethyl group, r(CH3)), 1199 cm−1 (NH2 twisting, t(NH2)), and
443 cm−1 (NH2 scissoring, sciss(NH2)) (Table 2).
The NH3 stretching (for MDA) is calculated at 3405 cm−1,
hile ν(NH2) (for “ecstasy”) is calculated at 3339 cm−1. Since
o significative intramolecular hydrogen-type interactions may
ccur in these molecules, the NH2/NH3 stretching vibrations
an only be affected by interaction with the chloride counterion,
hich may explain why they are not detected in the experi-
ental Raman spectra (added to the typical low intensity of
hese modes in Raman). Apart from the amino group stretching
odes, a quite good agreement was found between the exper-
mental and calculated frequencies for both MDA and MDMA
Fig. 8).
Raman spectroscopy was described to be a valuable tech-
ique for a complete characterisation of drugs of abuse, either
n seizure or biological samples. In that way it was applied to
asily identify MDA and MDMA, as well as to differentiate
hem from their synthetic precursors piperonal and 3,4-
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Fig. 6. Experimental Raman spectra (100–1750 cm−1, solid state, at 25 ◦C) for piperonal (A), 3,4-methylenedioxy--methyl--nitrostyrene (B), 3,4-
methylenedioxyamphetamine hydrochloride (MDA) (C), 3,4-methylenedioxymethamphetamine hydrochloride (MDMA) (D). (δ: in-plane deformation; Δ: in-plane
d isymm
F
m
a
(
1
a
o
t
a
o
t
weformation of skeleton atoms; ν: stretching; νs: symmetric stretching; νas: ant
ig. 5. The shaded area is expanded in Fig. 7.)
ethylenedioxy--methyl--nitrostyrene, through the signals
t 1445 cm−1 (aldehyde deformation, δ(CH)) and 1647 cm−1
chain C C stretching, ν(C C)) – typical of piperonal – and at
316 cm−1 (symmetric stretching of the nitro group, νs(NO2))
nd 1672 cm−1 (carbonyl stretching, ν(C O)) – characteristic
f 3,4-methylenedioxy--methyl--nitrostyrene (Fig. 6).
This study is, to the authors’ knowledge, the first attempt
o perform a complete Raman spectral assignment of these
c
i
l
petric stretching; r: rocking; t: twisting; τ: torsion. Atoms are represented as in
mphetamine-like systems, based on a structural analysis carried
ut by theoretical methods. It follows a similar conforma-
ional analysis performed for -methyl--nitrostyrenes [42],
hich are synthetic precursors of several amphetamines. Theseompounds can be detected as impurities or side-products
n illicitly produced MDMA [21,53], which are likely to
ead to severe adverse effects when contaminated with such
roducts.
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Fig. 7. Experimental Raman spectra (780–1120 cm−1, solid state, at 25 ◦C) for
MDA (A) and “ecstasy” (B) hydrochlorides. (Atoms are numbered according
to Fig. 5. δ: in-plane deformation; γ: out-of-plane deformation; r: rocking; ω:
wagging; sciss: scissoring; t: twisting.)
Fig. 8. Calculated (A) vs. experimental (B) Raman spectra (0–1750 cm−1) for
3,4-methylenedioxymethamphetamine hydrochloride.
Table 2
Selected experimental (solid state) and calculated (B3LYP/6-31G*) Raman
wavenumbers (cm−1) for the most stable conformer of “ecstasy” (MDMA)
Experimental Calculateda Approximate descriptionb
3339 ν(NH2)
3105 ν(C5H)
3083 3082 ν(C2H)
3079 ν(C5H) + ν(C6H)
3060 3072 ν(C27H3)
3054 3044 ν(C27H3)
3023 3038 ν(C9H3)
2994 2997 ν(C16H2)
2981 2992 ν(C7H2)
1634 ν(CC)ring
1611 1617 ν(CC)ring
1546 ω(NH2)
1516 1514 t(C16H2)
1512 r(NH2)
1459 1458 r(C27H3) + r(C9H3) + t(C7H2)
1443 1440 r(C27H3) + sciss(NH2)
1403 1395 γ(C27H3) + γ(C9H3) + sciss(C16H2) + r(NH2)
1371 1367 t(C7H2)
1249 1243 ω(CH2) + δ(C8H) + t(NH2)
1199 1204 t(CH2) + r(NH2)
1196 1178 r(C16H2)
1102 1108 ω(C16H2)
1094 1095 t(CH2) + δ(CH)ring
1081 1084 sciss(C16H2) + r(C27H3)
1040 1054 r(C9H3) + r(C27H3)
1023 1030 δ(OCO)
931 939 δ(OCO)
927 916 δ(OCO)
888 896 r(CH3) + r(CH2) + r(NH2) + δ(C5H) + δ(C6H)
869 868 r(NH2)
855 852 r(CH3) + r(NH2)
829 837 δ(C2H)
814 810 δ(C8H)
801 780 δ(CH)ring
777 758 ν(C C) + ν(CO)
725 706 ν(CO)ring
717 690 ν(C C)
633 617 Δ(CCC)ring
606 594 Δ(CCC)ring
535 522 Δ(CCC)ring
479 481 Γ (CCC) + Γ (CCN)
449 448 Γ (COC) + Γ (CCC) + Γ (CCN)
411 416 Γ (COC) + Γ (CCC) + Γ (CCN)
381 380 Γ (COC) + Γ (CCC)
341 368 Γ (COC) + Γ (C8NC27)
267 254 τ(C9H3)
252 241 τ(C9H3) + Γ (COC)
214 τ(C9H3)
193 193 τ(C27H3)
a Wavenumbers above 400 cm−1 are scaled by a factor of 0.9614P6.
b Atoms are labeled according to Fig. 5; δ: in-plane deformation; γ: out-of-
plane deformation; Δ: in-plane deformation of skeleton atoms; Γ : out-of-plane
d
s
w
4
d
teformation of skeleton atoms; ν: stretching; νs: symmetric stretching; νas: anti-
ymmetric stretching; r: rocking; sciss: scissoring; t: twisting; τ: torsion; ω:
agging.
. ConclusionsThe results of this work evidence a reliable interplay between
ifferent areas of research (synthesis, electrochemistry and spec-
roscopy, coupled with DFT calculations) which all together
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llow an insight into the physicochemical properties of a drug of
buse (MDMA) and its synthetic impurities, obtaining valuable
nformation for forensic or toxicological studies.
The development of new synthetic strategies for N-
ethylation is of the utmost importance, both chemically and
oxicologically. In fact, the pharmacological and toxicological
rofile of a drug is often a consequence of its metabolism, being
-methylation one of the most important pathways. For instance,
-methylated metabolites of amphetamine-like drugs of abuse
e.g. 3,4-dihydroxymethamphetamine) were found to be impor-
ant to understand the toxicological profile of “ecstasy”, at a
olecular level [54,55].
In the present work, along with the development of synthetic
trategies of N-methylation the characterisation of the com-
ounds was performed by electrochemical assays, as well as
y Raman spectroscopy experiments and quantum mechanical
DFT) calculations. From the voltammetric results for MDMA,
t was verified that the main anodic waves of the oxidation pro-
le are associated with the aromatic moiety and the secondary
mine group. A similar oxidative pattern was found for “ecstasy”
ynthetic impurities.
The vibrational (Raman) spectra, interpreted in the light of
FT calculations, allowed a rapid and unequivocal identification
f the compounds investigated, which is of the utmost relevance
or clinical, forensic and toxicological purposes. Raman spec-
roscopy has lately been shown to be a valuable tool for an
nambiguous detection of amphetamine-like products [14,17].
ctually, this technique provides a spectral fingerprint of the
ompounds tested and can thus be used to identify even chemi-
ally similar intermediates, as well as to trace back the precursor
aterials and the synthetic pathways employed in the prepara-
ion of the samples. In a near future, one will hopefully be able
o rely on a Raman database for both forensic and toxicological
tudies.
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